DARWIN EU®

DARWIN EU®

DATA ANALYSIS AND REAL WORLD INTERROGATION NETWORK The European Medicines Agency (EMA) is establishing a Coordination Centre for the Data Analysis and Real World Interrogation Network (DARWIN EU®). The role of the Coordination Centre is to develop and manage a network...
ERA4TB

ERA4TB

European Accelerator of Tuberculosis Regime The main objective of ERA4TB is to create a European open platform to accelerate the development of new regimens for the treatment of tuberculosis. The reach this goal, the consortium has set the following specific...
EU-PEARL

EU-PEARL

EU Patient-Centric Clinical Trial Platforms EU-PEARL is a strategic partnership between the public and private sectors to shape the future of clinical trials. This innovative and challenging enterprise aims to create a tested and trusted framework for patient-centric...
NEURONET

NEURONET

Efficiently Networking European Neurodegeneration Research The main aim of NEURONET is to set up an efficient platform to boost synergy and collaboration across the IMI projects of the Neurodegenerative Disorders (ND) portfolio, assisting in identifying gaps,...
TransBioLine

TransBioLine

Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project To Enable Development And Implementation Of Novel Safety Biomarkers The Synapse team is delighted to announce the launch of a new Innovative Medicines Initiative project, the...